Skip to main content

Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says

Bloomberg Markets
16 lis 2026, 10:22Crypto
Oryginał
1 min read

Denmark's Leo Pharma A/S is delaying its initial public offering plans beyond 2026, pushing back a listing previously targeted for this year.

The Danish pharmaceutical company had originally planned to go public in 2026 but has now extended that timeline indefinitely. No specific reasons for the delay were provided in the announcement.

Z.ai
Article written by AI
Z.ai GLM-4.5-FlashFree
Free AI articles150 of 150
No limit after signing in with Telegram